OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel ...

In a report released on February 23, Shlomo Rosenbaum from Stifel Nicolaus maintained a Buy rating on UL Solutions Inc. Class A (ULS – Research ...

Analysts Upbeat on DPZ’s Strategic Moves Among the bullish analysts, Chris O’Cull from Stifel Nicholas raised the price target on Domino’s to $500 from $470. He pointed out that Domino’s ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Andrew Nicholas, William Blair ... including technology and life sciences. David Grossman, Stifel: Asked about ASO growth potential and broker channel penetration. Simonds highlighted plans ...

HCR Wealth Advisors decreased its position in Microsoft Co. (NASDAQ:MSFT – Free Report) by 1.1% during the fourth quarter, ...

Paul Matteis, Stifel: Questioned the risks associated ... Asked about competitive dynamics for LYBALVI and ARISTADA. Todd Nichols noted a planned sales force expansion of 80 representatives ...

Stifel Nicolaus dropped their price target on ... In other news, insider Nicholas Daniel sold 1,500 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was ...

ST. LOUIS — After spending the last two seasons playing at various venues, including the Touhill Performing Arts Center and the Stifel Theater ... are Hannu Lintu, Nicholas McGegan, John ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

today announced that Nicholas Saccomano, Ph.D., President and Chief Executive Officer of OnKure Therapeutics, will present a corporate overview at the Stifel Healthcare Conference, on November 18 ...